4:56 AM
Aniket Kumar
As almost all major titles in the pharmaceutical industry, except Merk & Co. (MRK). It seems that the entire industry is undervalued, again, with the exception of Merk. Their multiples are extremely high in the 120 in comparison with other populations in this industry, but I never understood why.
Like Johnson & Johnson (JNJ) and Bristol-Myers Squibb Co. Its P / E is in the range 12.
I especially like the Johnson & Johnson, because they are not popular now an archive, because of their high points of last year. But I think this is still a strong company and is a bit 'counter, I think this stock is undervalued.
Here are a few that I like individual titles in 2011. I like Wal-Mart (WMT). Yes, they took a big hit during the recession, the dollar stores has made the market share, but I think they are back in force. I like them because I believe that current concerns about Wal-Mart because their work is undervalued.
0 comments:
Post a Comment